An observational study in Kidney Injury, Acute, sponsored by Lanyue Zhu. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-02.
Sponsored by Lanyue Zhu · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 168 studies in Acute Kidney Injury with a site in China — 46 open to participants now, 54 under way, 1 of them phase 3. Acute Kidney Injury · China.
Among the 168 studies in Acute Kidney Injury with a site in China, this one is the 13th largest by planned enrollment of the 105 observational ones that give a count, is one of 10 that started in 2025, is one of 105 observational ones, reaches primary completion later than 21 of the 53 other live ones, and was the 133rd registered.
1,693 studies on the registry are indexed under Acute Kidney Injury; 392 are open to participants now.
Browse Acute Kidney Injury studies →46 of the 168 studies in Acute Kidney Injury with a site in China are open now. Recruiting first, the newest first:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Sites in China
Ages 18+
China National Center for Cardiovascular Diseases · Sites in China
Ages 18+
Jinling Hospital, China · Sites in China
Ages 18–75
Sir Run Run Shaw Hospital · Sites in China
Ages 18+
China National Center for Cardiovascular Diseases · Sites in China
Ages 18+
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 229 Acute Kidney Injury studies recruiting now, 161 (70%) set no upper age limit and 35 (15%) stop at 75 or younger; 22 take children under 18; 25 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
168 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 11 · Phase 3 3 · Phase 4 10
First in 2004; this study’s year is marked. 10 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 10,000 is above the median of 160 across 814 observational studies indexed under Acute Kidney Injury.
Median enrollment 152 across the 63 interventional studies, 472 across the 105 observational. Of the 82 that completed or were terminated, 4 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 168 have an industry lead sponsor. The 10 most frequent:
Lanyue Zhu is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Lanyue Zhu has 2 studies filed under Acute Kidney Injury — fewer than ten, so there is no comparison to draw.
19 of the studies in Acute Kidney Injury with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07850947Second Affiliated Hospital, Zhejiang University, School of MedicineAn Observational Study of Percutaneous Glomerular Filtration Rate (TGFR) in the Early Warning of Contrast-induced Acute Kidney Injury During the Peri-examination Period of Emergency Enhanced CT | 2026-12 |
| NCT07672860Jinling Hospital, ChinaPerioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal Tumors | 2026-12 |
| NCT07602465Zhongda HospitalThe Impact of Blood Pressure Variability During the Induction and Surgical Periods on Postoperative Acute Kidney Injury | 2026-12-01 |
| NCT06939387Zhejiang Provincial People's HospitalDrug-induced Kidney Injury Model | 2026-12-30 |
| NCT04789733The Cleveland ClinicThe GUARDIAN Pilot Trial | 2026-12-31 |
Add all 19 to your calendar (.ics) → With an account.
Among the 168 studies in Acute Kidney Injury with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Primary objectives of this study is to develop and validate a predictive model for acute kidney injury after non-cardiac surgery based on machine learning. Secondary objectives of this study is to incorporate frailty assessment as a new predictor into the model and measure its incremental value was measured.
The data in this study are divided into two parts: retrospective and prospective. The retrospective data served as the development set, sourced from the electronic medical records of adult patients who underwent non-cardiac surgery during hospitalization between July 2015 and June 2025. The prospective data constituted an external (temporal) validation set, with data collection commencing in July 2025 and expected to conclude in February 2026.
Patients who are scheduled to undergo surgery at Zhongda Hospital Southeast University.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The development group was used for model development, five-fold cross-validation, and model optimization. The investigators collected a comprehensive set of variables for feature selection, including preoperative demographic characteristics (sex, age, body mass index, marital status, occupation, etc.), laboratory indicators (routine blood and urine tests, liver and kidney function, coagulation function, etc.), preoperative comorbidities, and surgical information (surgical department, surgical classification, American Society of Anesthesiologists physical status classification, intraoperative position, fluid intake and output, vital signs, intraoperative medication use, etc.). Subsequently, multiple machine learning methods, including logistic regression, extreme gradient boosting, decision tree, random forest, and Bayesian approaches, were employed for model building and optimization.
Other: No intervention measures were used.
The external (time) validation group is used for future generalization ability assessment. The investigators prospectively collected patient-related data. In addition to the same variables as those in the development group and the testing group, the investigators also evaluated and collected the frailty status of patients before the operation, and recorded prognostic indicators such as the incidence of in-hospital complications, in-hospital mortality, length of hospital stay and hospitalization cost of patients. The investigators used the data from the external (time) validation group to validate the model performance, incorporated the frailty assessment as a new predictor into the model, calculated the incremental values and evaluated the performance of the updated model.
Other: No intervention measures were used.
The exposure factors were the perioperative related operations experienced by the patients and their individual conditions
Acute kidney injury
Time frame: Within 7 days after the operation
Postoperative complications
Time frame: Perioperative period
Postoperative mortality
Time frame: Perioperative period
Hospitalization costs
Time frame: Perioperative period
Hospital stays
Time frame: Perioperative period
Started Jul 2025 (actual). Primary completion is estimated for Dec 2026, 17 months after the start.
Of 350 non-industry observational studies under Acute Kidney Injury, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 42. This study's planned 17 months is below that.
Counting every sponsor, half of 365 studies reached it within 24 months; a quarter within 12 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Lanyue Zhu